Detecting fetal subchromosomal aberrations by MPS: An unexpected discrepancy between amniocyte DNA and ccffDNA

Prenatal Diagnosis

Volumn 34, Issue 4, 2014, Pages 402-405

  Buysse, Karen ^a   de Ligt, Joep ^a   Janssen, Irene M ^a   van Bon, Bregje W M ^a   Gomes, Ingrid ^a   Hehir Kwa, Jayne ^a   Eggink, Alex J ^b   van Vugt, John M G ^a   Vissers, Lisenka E L M ^a   Geurts van Kessel, Ad ^a   Faas, Brigitte H W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CCFFDNA; DNA; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR; ZIC2 PROTEIN, HUMAN;

ADULT; AMNIOCENTESIS; AMNION CELL; ARTICLE; CASE REPORT; CELL FREE SYSTEM; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; DNA ISOLATION; DNA MICROARRAY; DNA SEQUENCE; FEMALE; FETUS KARYOTYPING; GENETIC ANALYZER; GENOTYPE; GESTATIONAL AGE; HOLOPROSENCEPHALY; HUMAN; KARYOTYPE 46,XX; KIDNEY AGENESIS; MASSIVELY PARALLEL SEQUENCING; MATERNAL BLOOD; PATIENT REFERRAL; PREGNANT WOMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SUBCHROMOSOMAL ABERRATION; BLOOD; CHEMISTRY; CHROMOSOME 13; FETUS; GENE DELETION; GENETICS; HIGH THROUGHPUT SEQUENCING; PREGNANCY; PROCEDURES;

ADULT; AMNIOCENTESIS; CHROMOSOMES, HUMAN, PAIR 13; DNA; FEMALE; FETUS; GENE DELETION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HOLOPROSENCEPHALY; HUMANS; NUCLEAR PROTEINS; PREGNANCY; TRANSCRIPTION FACTORS;

EID: 84898059356     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4312     Document Type: Article

References (12)

1. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350(9076):485-7.
2. Chiu RW, Chan KC, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008;105(51):20458-63.
3. Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008;105(42):16266-71.
4. Srinivasan A, Bianchi DW, Huang H, et al. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 2013;92(2):167-76.
5. Sehnert AJ, Rhees B, Comstock D, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011;57(7):1042-9.
6. Peters D, Chu T, Yatsenko SA, et al. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med 2011;365(19):1847-8.
7. Jensen TJ, Dzakula Z, Deciu C, et al. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem 2012;58(7):1148-51.
8. Chen S, Lau TK, Zhang C, et al. A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing. Prenat Diagn 2013;33(6):584-90.
9. Faas BH, de Ligt J, Janssen I, et al. Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells. Expert Opin Biol Ther 2012;12(Suppl 1):S19-26.
10. Choi H, Lau TK, Jiang FM, et al. Fetal aneuploidy screening by maternal plasma DNA sequencing: 'false positive' due to confined placental mosaicism. Prenat Diagn 2013;33(2):198-200.
11. Lau TK, Jiang FM, Stevenson RJ, et al. Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service. Prenat Diagn 2013;33(6):602-8.
12. Pan M, Li FT, Li Y, et al. Discordant results between fetal karyotyping and non-invasive prenatal testing by maternal plasma sequencing in a case of uniparental disomy 21 due to trisomic rescue. Prenat Diagn 2013;33(6):598-601.